UBS Group’s Carlsmed CARL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$171K Sell
12,168
-4,581
-27% -$63.6K ﹤0.01% 6857
2026
Q2
$174K Buy
16,749
+6,446
+63% +$67.8K ﹤0.01% 6872
2026
Q1
$93.2K Sell
10,303
-383
-4% -$4.63K ﹤0.01% 7038
2025
Q4
$132K Sell
10,686
-13,517
-56% -$180K ﹤0.01% 6772
2025
Q3
$324K Buy
+24,203
New +$331K ﹤0.01% 6383

Other funds holding CARL

UBS Group's CARL Position: Q3 2026 in Review

UBS Group reduced its Carlsmed (CARL) stake by 27% in Q3 2026, selling an estimated $63.6K and leaving 12,168 shares worth $171K. The position accounts for ﹤0.01% of the portfolio, ranked #6857.

UBS Group first reported a position in CARL in Q3 2025 and has held it in 5 quarters since. The position peaked at $324K in Q3 2025. 86 funds tracked by Wall St. Rank hold CARL as of Q3 2026.

  • UBS Group held 12,168 shares of Carlsmed worth $171K as of Q3 2026.
  • UBS Group sold 4,581 Carlsmed shares in Q3 2026, an estimated $63.6K.
  • Carlsmed made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #6857 holding.
  • UBS Group first reported a position in Carlsmed in Q3 2025 and has held it in 5 quarters since.
  • UBS Group's Carlsmed position peaked at $324K in Q3 2025.
  • 86 funds tracked by Wall St. Rank held Carlsmed as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.